Could a traditional fermented buffalo milk boost breastfeeding success?

NCT ID NCT07718087

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study tests whether combining structured nutrition education with a daily supplement of Dali ni Horbo—a traditional Batak fermented buffalo milk—can improve the diets of breastfeeding mothers, support exclusive breastfeeding, and promote healthy growth and gut bacteria in their infants. About 50 mothers with healthy babies aged 0-1 month from primary healthcare centers in Medan, Indonesia, will either receive the education and supplement or standard care. Researchers will measure changes in maternal nutrient intake, breastfeeding practices, infant growth, and infant gut microbiota.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
structured lactation nutrition education and Dali ni Horbo (traditional Batak fermented buffalo milk) supplementation
What this could lead to
If successful, this approach could offer a simple, culturally relevant way to improve nutrition for breastfeeding mothers and support healthy infant growth.
What could go wrong
This is a small, early-stage trial with only 50 participants, so results may not apply broadly. The supplement is a traditional food, and its effects may be modest or hard to separate from the education component.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 40 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Lactating mothers aged 18-40 years. * Having a healthy, singleton infant aged 0-1 month at enrollment. * Residing within the service areas of the participating primary healthcare centers in Medan, Indonesia. * Currently breastfeeding and intending to continue breastfeeding throughout the study period. * Able to consume Dali ni Horbo and willing to follow the assigned intervention. * Willing to participate in all study assessments, including dietary assessment, anthropometric measurements, and infant stool collection. * Able to communicate effectively and complete the study questionnaires. * Willing to provide written informed consent. Exclusion Criteria: * Mothers or infants with medical conditions that may significantly affect breastfeeding, maternal nutritional status, nutrient metabolism, or infant growth. * Mothers with severe postpartum complications or conditions requiring hospitalization. * Infants with congenital abnormalities, gastrointestinal disorders, metabolic diseases, severe infections, or other conditions affecting feeding or growth. * Infants born preterm or with low birth weight, according to the study protocol. * Mothers with a known allergy or intolerance to buffalo milk, cow's milk, or dairy products. * Mothers following a medically prescribed restrictive diet that could affect the study outcomes. * Current participation in another nutritional or clinical intervention study. * Use of nutritional supplements, probiotics, antibiotics, or other treatments that may substantially affect maternal nutrient intake or infant gut microbiota, unless permitted by the study protocol. * Inability or unwillingness to comply with the intervention and follow-up procedures.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Maternity care are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Breast Feeding

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Nutrition Departement, Universitas Sumatera Utara, Medan, Indonesia

    Medan, North Sumatera, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.